Antiarrhythmic and Symptomatic Effect of ISIS CRP Rx Targeting CRP in Paroxysmal Atrial Fibrillation
Clinical trial NCT01710852 · COMPLETED
Trial details
- NCT number
- NCT01710852
- Sponsor
- Ionis Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-10-01
- Primary completion
- 2014-04-01
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.